Barr Labs Inc Company Profile
What is the competitive landscape for BARR LABS INC
BARR LABS INC has sixteen approved drugs.
There are two tentative approvals on BARR LABS INC drugs.
Drugs and US Patents for Barr Labs Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Barr Labs Inc | CLOZAPINE | clozapine | TABLET, ORALLY DISINTEGRATING;ORAL | 090308-004 | Nov 25, 2015 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Barr Labs Inc | MINOCYCLINE HYDROCHLORIDE | minocycline hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 065485-002 | Mar 17, 2009 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Barr Labs Inc | METHYLPHENIDATE HYDROCHLORIDE | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 079031-004 | Oct 15, 2014 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Barr Labs Inc | MINOCYCLINE HYDROCHLORIDE | minocycline hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 065485-001 | Mar 17, 2009 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

